Insmed, Inc. (INSM)
143.48
-6.40
(-4.27%)
USD |
NASDAQ |
Mar 05, 16:00
143.48
0.00 (0.00%)
After-Hours: 16:50
Insmed Cash from Investing (Quarterly) : 389.41M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Biogen, Inc. | -1.232B |
| Madrigal Pharmaceuticals, Inc. | 27.58M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| CorMedix, Inc. | -291.32M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -247.60M |
| Cash from Financing (Quarterly) | 33.86M |
| Free Cash Flow | -997.58M |
| Free Cash Flow Per Share (Quarterly) | -1.377 |
| Free Cash Flow to Equity (Quarterly) | -305.09M |
| Free Cash Flow to Firm (Quarterly) | -273.49M |
| Free Cash Flow Yield | -3.50% |